-39.5%
OWL vs GSK
+22.9%
-62.4%
-55.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.0% | -1.0% | -2.9% | -4.0% |
| 7D | -11.9% | -5.4% | -6.5% | -12.3% |
| 30D | -13.7% | -4.6% | -9.1% | -13.9% |
| 3M | +12.3% | -5.1% | +17.4% | +11.9% |
| 6M | +15.0% | -11.4% | +26.4% | +12.6% |
| YTD | -25.7% | +0.7% | -26.4% | -23.1% |
| 1Y | -39.5% | +23.0% | -62.5% | -32.4% |
| All | -39.5% | +22.9% | -62.4% | -32.4% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling